These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method. Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC; Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290 [TBL] [Abstract][Full Text] [Related]
9. CD38 is a key enzyme for the survival of mouse microglial BV2 cells. Ma Y; Jiang J; Wang L; Nie H; Xia W; Liu J; Ying W Biochem Biophys Res Commun; 2012 Feb; 418(4):714-9. PubMed ID: 22293203 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of CD38 activation markers by atorvastatin in HIV patients with undetectable viral load. De Wit S; Delforge M; Necsoi CV; Clumeck N AIDS; 2011 Jun; 25(10):1332-3. PubMed ID: 21508802 [TBL] [Abstract][Full Text] [Related]
12. The use of CD38 expression by monoclonal B lymphocytes as a prognostic factor in B-cell chronic lymphocytic leukemia. Boonstra JG; von't Veer MB; Gratama JW J Biol Regul Homeost Agents; 2004; 18(3-4):340-6. PubMed ID: 15786702 [TBL] [Abstract][Full Text] [Related]
13. Oxytocin: the neuropeptide of love reveals some of its secrets. Neumann ID Cell Metab; 2007 Apr; 5(4):231-3. PubMed ID: 17403367 [TBL] [Abstract][Full Text] [Related]
14. CD38 and CD157: a long journey from activation markers to multifunctional molecules. Quarona V; Zaccarello G; Chillemi A; Brunetti E; Singh VK; Ferrero E; Funaro A; Horenstein AL; Malavasi F Cytometry B Clin Cytom; 2013; 84(4):207-17. PubMed ID: 23576305 [TBL] [Abstract][Full Text] [Related]
15. Monitoring of CD95 and CD38 expression in peripheral blood T lymphocytes during active human cytomegalovirus infection after orthotopic liver transplantation. Wang Y; Liu Y; Han R; Li Q; Yao Z; Niu W; Yuan Y; Tang Z; Zhu Z; Shen Z J Gastroenterol Hepatol; 2010 Jan; 25(1):138-42. PubMed ID: 19817952 [TBL] [Abstract][Full Text] [Related]
16. E2A is a transcriptional regulator of CD38 expression in chronic lymphocytic leukemia. Saborit-Villarroya I; Vaisitti T; Rossi D; D'Arena G; Gaidano G; Malavasi F; Deaglio S Leukemia; 2011 Mar; 25(3):479-88. PubMed ID: 21212793 [TBL] [Abstract][Full Text] [Related]
17. Zap-70 and CD38 as predictors of IgVH mutation in CLL. Cruse JM; Lewis RE; Webb RN; Sanders CM; Suggs JL Exp Mol Pathol; 2007 Dec; 83(3):459-61. PubMed ID: 17931624 [TBL] [Abstract][Full Text] [Related]
18. Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft model. Aydin S; Grabellus F; Eisele L; Möllmann M; Hanoun M; Ebeling P; Moritz T; Carpinteiro A; Nückel H; Sak A; Göthert JR; Dührsen U; Dürig J Eur J Haematol; 2011 Jul; 87(1):10-9. PubMed ID: 21692849 [TBL] [Abstract][Full Text] [Related]
19. CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation. Pittner BT; Shanafelt TD; Kay NE; Jelinek DF Leukemia; 2005 Dec; 19(12):2264-72. PubMed ID: 16208411 [TBL] [Abstract][Full Text] [Related]
20. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells. Glasová M; Koníková E; Stasáková J; Babusíková O Neoplasma; 1998; 45(2):88-95. PubMed ID: 9687889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]